Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016.
Causes for hospitalisation
HIV
Poisson regression model
cohort study
hospitalisation rates
multiple failure-time data analysis
Journal
Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
28
3
2020
Statut:
ppublish
Résumé
Here we evaluated hospitalisation rates and associated risk factors of human immunodeficiency virus (HIV)-infected individuals who were followed up in an Italian reference hospital from 1998 to 2016. Incidence rates (IR) of hospitalisations were calculated for five study periods from 1998 to 2016. The random-effects Poisson regression model was used to assess risk factors for hospitalisation including demographic and clinical characteristics. To consider that more events may occur for the same subject, multiple failure-time data analysis was also performed for selected causes using the Cox proportional hazards model. We evaluated 2031 patients. During 13 173 person-years (py) of follow-up, 3356 hospital admissions were carried out for 756 patients (IR: 255 per 1000 py). IR decreased significantly over the study period, from 634 in 1998-2000 to 126 per 1000 py in 2013-2016. Major declines were detected for AIDS-defining events, non-HIV/AIDS-related infections and neurological diseases. Older age, female sex, longer HIV duration and HCV coinfection were associated with a higher hospitalisation risk, whereas higher CD4 nadir and antiretroviral therapy were associated with a reduced risk. Influence of advanced HIV disease markers declined over time. Hospitalisation rates decreased during the study period in most causes. The relative weight of hospitalisations for non-AIDS-related tumours, cardiovascular, respiratory and kidney diseases increased during the study period, whereas those for AIDS-defining events declined.
Identifiants
pubmed: 30869037
pii: S0950268819000098
doi: 10.1017/S0950268819000098
pmc: PMC6518563
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e89Références
AIDS. 2000 Jul 28;14(11):1545-52
pubmed: 10983641
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):143-52
pubmed: 11404536
AIDS Res Hum Retroviruses. 2002 May 1;18(7):501-6
pubmed: 12015903
Lancet. 2003 Jul 5;362(9377):22-9
pubmed: 12853195
HIV Med. 2004 Nov;5(6):437-47
pubmed: 15544697
AIDS. 2008 Jul 11;22(11):1345-54
pubmed: 18580614
BMJ. 2008 Dec 09;337:a2467
pubmed: 19066258
AIDS. 2009 Aug 24;23(13):1743-53
pubmed: 19571723
AIDS. 2010 Jun 1;24(9):1329-39
pubmed: 20559038
Lancet. 2010 Jul 3;376(9734):49-62
pubmed: 20609987
J Acquir Immune Defic Syndr. 2010 Jul;54(3):248-57
pubmed: 20658748
BMC Infect Dis. 2014 Oct 10;14:536
pubmed: 25300638
J Infect Dis. 2015 Jun 1;211(11):1692-702
pubmed: 25512624
J Int Assoc Provid AIDS Care. 2015 Sep-Oct;14(5):408-14
pubmed: 25656860
BMC Health Serv Res. 2015 Apr 08;15:144
pubmed: 25889920
Clin Exp Immunol. 2017 Jan;187(1):44-52
pubmed: 27198731
Braz J Infect Dis. 2017 Mar - Apr;21(2):190-195
pubmed: 27918889
Clin Infect Dis. 2017 Aug 1;65(3):469-476
pubmed: 28444155
Medicine (Baltimore). 2017 May;96(18):e6812
pubmed: 28471983
Stat Med. 1994 Nov 15;13(21):2233-47
pubmed: 7846422
N Engl J Med. 1998 Mar 26;338(13):853-60
pubmed: 9516219